Investigation of the effect of oral L-arginine on pulmonary hypertension in patients with thalassemia major
Phase 3
- Conditions
- Beta thalassemia.
- Registration Number
- IRCT20191218045785N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Major or intermedia thalassemia with PAP> 30
Systemic blood pressure over 60/90
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary arterial pressure. Timepoint: Baseline (before intervention) and 6 and 30 days after L-arginine administration. Method of measurement: Echocardiography.
- Secondary Outcome Measures
Name Time Method Systemic blood pressure. Timepoint: Baseline (before intervention) and 6 and 30 days after L-arginine administration. Method of measurement: Blood pressure monitor.